Breast Cancer Care comments on new treatment for advanced HER2-positive breast cancer patients as Kadcyla (trastuzumab emtansine) gets regulatory...

13 February 2014

Comment from Breast Cancer Care on a North American study published in the British Medical Journal which suggests that women with a faulty BRCA...

12 February 2014

Commenting on an international health study by the Organisation for Economic Co-operation and Development (OECD) showing that Britain's survival...

21 November 2013

Commenting on latest NICE guidance recommending the use of the Oncotype DX test to help make treatment decisions for patients with early stage...

30 September 2013

Commenting on the subcutaneous (SC) injection for Herceptin for patients with HER2-postive breast cancer being granted a license by the European...

24 September 2013

Two of our patient information publications have been recognised by the British Medical Association (BMA) in a prestigious annual awards scheme...

18 September 2013

Commenting on the updated NHS breast screening leaflet and invitation letter in use from today (Monday 16 September 2013) Jackie Harris Clinical...

16 September 2013

Commenting on the decision today (7 August 2013) by the National Institute for Health and Care Excellence (NICE) on guidance for the RD-100i OSNA...

7 August 2013

Commenting on the decision today (6 August 2013) by the National Institute for Health and Clinical Excellence (NICE) not to recommend pertuzumab (...

6 August 2013